Teva received FDA approval for WELTRUZA, a once-monthly subcutaneous olanzapine injection for adults with schizophrenia, with ...

Col. Wayne Sanders (Ret.) of Bloomberg Intelligence examines what he calls the "hornet's nest" of increased activity in the ...

Chris Verrone, partner and chief market strategist at Baird Strategas, sees equity markets as "highly rotational" and doesn't ...

Gorilla Technology signed a non-binding LOI to acquire its first U.S. data center, with 6 MW live capacity and a potential ...

Sagimet reported 52-week denifanstat acne data showing 57% IGA success, 72% lower total lesions and 77% fewer inflammatory ...

Profound Medical entered a co-education agreement with Telix covering PSMA-PET imaging and its MRI-guided TULSA-PRO prostate ...

Arcutis reported ZORYVE data showing 34.4% infant skin clearance in atopic dermatitis and stronger Week 8 psoriasis responses ...

Valion Bio and Shear Kershman Laboratories completed formulation work on a needle-free oral mucosal version of Entolimod for ...

Seaport Therapeutics reported Phase 1 GlyphAgo data showing 6.8-fold higher agomelatine bioavailability and substantially ...

Johnson & Johnson reported two-year ICONIC-LEAD data showing at least 72% PASI 90 at Week 112, sustained itch improvement and ...

Horizon Aircraft reported more than $70 million in cash and expects its Cavorite X7 demonstrator to be completed by the first ...

Pebblebrook Hotel Trust sold the 174-room Hotel Zags in Portland for $10 million after the property recorded estimated ...